150 related articles for article (PubMed ID: 37501844)
21. Knockdown of MUC16 (CA125) Enhances the Migration and Invasion of Hepatocellular Carcinoma Cells.
Huang Y; Huang X; Zeng J; Lin J
Front Oncol; 2021; 11():667669. PubMed ID: 34150633
[TBL] [Abstract][Full Text] [Related]
22. Retracted: New Pyroptosis-Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9809725. PubMed ID: 37621615
[TBL] [Abstract][Full Text] [Related]
23. Retracted: Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9828737. PubMed ID: 37266270
[TBL] [Abstract][Full Text] [Related]
24. Retracted: Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9834327. PubMed ID: 37860371
[TBL] [Abstract][Full Text] [Related]
25. Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9781974. PubMed ID: 37547638
[TBL] [Abstract][Full Text] [Related]
26. Retracted: Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9865740. PubMed ID: 38094394
[TBL] [Abstract][Full Text] [Related]
27. Retracted: Effect of Comprehensive Nursing Approach in Perioperative Stage of Patients with Hepatocellular Carcinoma Interventional Therapy.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9789353. PubMed ID: 38093865
[TBL] [Abstract][Full Text] [Related]
28. Retracted: Risk Factors for Brain Metastasis of Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9783892. PubMed ID: 37772007
[TBL] [Abstract][Full Text] [Related]
29. [Retracted] KIFC1 promotes the proliferation of hepatocellular carcinoma
Wang X; Wang M; Li XY; Li J; Zhao DP
Oncol Lett; 2023 Aug; 26(2):345. PubMed ID: 37427345
[TBL] [Abstract][Full Text] [Related]
30. Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.
International BR
Biomed Res Int; 2021; 2021():1916343. PubMed ID: 33728325
[TBL] [Abstract][Full Text] [Related]
31. Retracted: Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9853278. PubMed ID: 37266250
[TBL] [Abstract][Full Text] [Related]
32. Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies.
BioMed Research International
Biomed Res Int; 2018; 2018():4560161. PubMed ID: 29854758
[TBL] [Abstract][Full Text] [Related]
33. Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies.
BioMed Research International
Biomed Res Int; 2016; 2016():2514067. PubMed ID: 27127781
[TBL] [Abstract][Full Text] [Related]
34. Retracted: Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9808276. PubMed ID: 37503372
[TBL] [Abstract][Full Text] [Related]
35. Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9806284. PubMed ID: 37565158
[TBL] [Abstract][Full Text] [Related]
36. [Retracted] KIF2C promotes the proliferation of hepatocellular carcinoma cells
Gao Z; Jia H; Yu F; Guo H; Li B
Exp Ther Med; 2023 Aug; 26(2):396. PubMed ID: 37456172
[TBL] [Abstract][Full Text] [Related]
37. [Retracted] miR‑365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl‑2.
Li M; Yang Y; Kuang Y; Gan X; Zeng W; Liu Y; Guan H
Exp Ther Med; 2023 Mar; 25(3):102. PubMed ID: 36761039
[TBL] [Abstract][Full Text] [Related]
38. Retracted: Imaging Diagnosis and Interventional Treatment for Hepatocellular Carcinoma Combined with Arteriovenous Fistula.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9824820. PubMed ID: 37860470
[TBL] [Abstract][Full Text] [Related]
39. [Retracted] Actin‑binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice.
Jia H; Gao Z; Yu F; Guo H; Li B
Exp Ther Med; 2023 Sep; 26(3):421. PubMed ID: 37602301
[TBL] [Abstract][Full Text] [Related]
40. Retracted: Perspectives of Molecular Therapy-Targeted Mitochondrial Fission in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9856592. PubMed ID: 38230168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
